To determine the value of peritoneal washing cytology (CY) in determining resectability of pancreatic cancer. Summary Background Data: CY has been used widely in the diagnosis and staging of several cancers. However, its predictive value in identifying potentially resectable pancreatic cancer is undetermined. Methods: Peritoneal washing samples were collected from 233 patients with pancreatic cancer between June 1991 and August 2006. A total of 157 patients had resectable and 76 had unresectable lesions. Correlations between CY status and clinicopathologic parameters with overall survival rates were analyzed. Results: Malignant cells were identified in samples from 21 patients (13.4%) with resectable tumors and 27 patients (35.5%) with unresectable tumors. CYϩ was more frequent in large tumors (Ն2 cm) than small tumors (Ͻ2 cm; P ϭ 0.034). CY status did not correlate with any other clinicopathologic parameter. The overall survival of CYϩ patients was worse than that of CYϪ patients (P ϭ 0.047). Median survival following resection was 13.6 months for CYϩ patients and 13.5 months for CYϪ patients. Among the patients who had unresectable lesions, median survival time was 5.9 months for CYϩ and 6.1 months for CYϪ patients. However, among CYϩ patients, those who underwent resection lived longer than those who did not (P ϭ 0.019). Conclusions: Cytologic status has little predictive value for survival, and patients whose pancreatic cancer would otherwise be considered resectable should not be denied curative resection solely because they are CYϩ. (Ann Surg 2007;246: 254 -258) From the
P ancreatic cancer continues to be the gastrointestinal malignancy with the worst prognosis, and only 3% of patients survive 5 years after diagnosis. Surgical resection offers the only chance for cure; and although the resection rate has increased gradually, the prognosis remains poor. 1 Peritoneal washing cytology (CY) has been used widely in the diagnosis and staging of ovarian, endometrial, and gastric cancer. Malignant cells can be identified in 7% to 30% of peritoneal washing samples from patients with pancreatic cancer. [2] [3] [4] [5] [6] [7] [8] [9] However, the clinical significance of their presence is yet to be determined. Prior studies have suggested that positive peritoneal cytology (CYϩ) may be a marker for advanced disease, predictive of early metastasis and shortened survival, and thus should be considered a contraindication for attempts at curative resection. 4, 5 On the other hand, several authors have found no correlation between CYϩ and the development of peritoneal metastasis postoperatively. Consequently, these investigators claim that CYϩ status in the absence of macroscopic peritoneal metastasis is not a contraindication for radical surgery. [7] [8] [9] In the current study, we examined peritoneal washings from 233 patients with pancreatic cancer. The purpose was to determine what, if any, whether relationship exists between cytology results and clinicopathologic parameters and peritoneal washing cytology correlates with survival.
PATIENTS AND METHODS

Patients Selection and Study Design
Peritoneal washing samples were collected from 233 pancreatic cancer patients treated at the Department of Surgery II, Nagoya University, between June 1991 and August 2006. All 233 patients were considered candidates for curative resection after a meticulous preoperative work-up. The cohort included 156 men and 77 women, with the median age of 61.9 years (range, 32-84 years). All patients were followed until death or through August 2006. The patients were followed for mean of 18.3 months or until death. Extended radical resection (D2) was performed for all cases in the absence of macroscopic liver or peritoneal metastases. A total of 157 patients had resectable lesions, while the other 76 patients had macroscopic hepatic metastases, macroscopic peritoneal metastases, or extensive local invasion. Immediately after laparotomy, 200 mL of isotonic heparinized saline was introduced into the subhepatic space and the pouch of Douglas. After gentle agitation, as much fluid was collected as possible using a syringe and quill. Smears were made from the centrifuged deposit and, after conventional Papanicolaou and Giemsa staining, examined by at least 2 experienced pathologists. 7 All surgical specimens were examined histopathologically after being fixed and stained with hematoxylin and eosin. Pathologic findings were evaluated in accordance with the second English edition of the Classification of Pancreatic Carcinoma proposed by the Japan Pancreas Society, 10 : pT1, tumor limited to the pancreas (Յ2 cm in the greatest dimension); pT2, tumor limited to the pancreas (Ͼ2 cm in the greatest dimension); pT3, tumor extending directly into the bile duct, duodenum, or peripancreatic tissues; and pT4, tumor extending directly into the adjacent large vessels, plexus, stomach, colon, or spleen. This classification scheme is more detailed than the classification of the Union Internationale Contre le Cancer. 11 The tumor location and extension were classified according to the 6th edition of the UICC classification.
Statistical Analysis
The significance of correlations between cytologic results and clinicopathologic parameters were determined using Fisher exact test or the 2 test. Overall survival rates were calculated using the Kaplan-Meier method, and the difference in survival curves was analyzed using the log-rank test. Independent prognostic factors were identified by multivariate analysis using the Cox proportional hazards regression model. Data are expressed as mean Ϯ SD. The level of statistical significance was set at P Ͻ 0.05.
RESULTS
Of the 233 patients, 76 had unresectable lesions due to the presence of macroscopic hepatic metastasis (n ϭ 38), macroscopic peritoneal metastasis (n ϭ 21), both macroscopic hepatic and peritoneal metastases (n ϭ 5), or extensive local invasion (n ϭ 22). The remaining 157 patients underwent pancreatoduodenectomy (n ϭ 81), pylorus-preserving pancreatoduodenectomy (n ϭ 29), distal pancreatectomy (n ϭ 30), and total pancreatectomy (n ϭ 17). The conclusive stages of the 157 patients who underwent resection according to the TNM classification 11 were IA in 2 cases, IB in 4 cases, IIA in 31 cases, IIB in 72 cases, III in 15 cases, and IV in 33 cases.
Malignant cells were more often present in the peritoneal washings from patients with unresectable lesions (27 cases, 35.5%) than those with resectable disease (21 cases, 13.4%; Table 1 ) (P ϭ 0.0002). Among the 21 patients who had unresectable lesions due to the presence of macroscopic peritoneal metastasis, 15 (71.4%) were CYϩ.
Patients with large tumors (Ն2 cm) were more likely to be CYϩ than those with small tumors (Ͻ2 cm; P ϭ 0.034). However, no other correlation between cytologic status and clinicopathologic parameter existed (invasion of the anterior pancreatic capsule or retroperitoneal tissue, bile duct inva-sion, duodenal invasion, portal vein invasion, arterial invasion, perineural invasion, lymph node metastasis, lymph vessel invasion, vascular invasion, local tumor spread, location, or residual disease status) ( Table 2 ). Of 157 resectable cases, cancer of 6 cases involved the whole pancreas and those of 32 cases occupied the body. Prognosis of these patients were poor compared with lesions localized to the pancreatic head, but no correlation between the CY status and tumor location was found at this time, partially owing to the rarity of CYϩ cases among lesions located in the pancreatic body. Median survival time of R0 patients (14.5 months) was longer than that of R1 patients (9.2 months, P ϭ 0.015) even when the CY status was not reflected in the R classification. In addition, no correlation was found between the CY status and the extent of residual disease. Among patients who had unresectable lesions, patients with macroscopic peritoneal metastases had a higher incidence of CYϩ than those without macroscopic peritoneal metastases (P ϭ 0.0001). On the other hand, CY status did not correlate with the presence or absence of hepatic metastases.
The overall survival of CYϩ patients was shorter than of CYϪ patients (P ϭ 0.047; Fig. 1 ). For patients who underwent resection, however, the median survival time of CYϩ patients (13.6 months) was almost identical to that of CYϪ patients (13.5 months, P ϭ 0.269; Fig. 2 ). This unexpected lack of a difference in survival was seen among patients with unresectable lesions as well (5.9 months for CYϩ and 6.1 months for CYϪ, P ϭ 0.977; Fig. 2 ). Furthermore, no difference in survival according to CYϩ status was observed among patients with stages III and IV disease. There was a marked difference in survival between CYϩ patients who underwent resection and those who did not (P ϭ 0.019; Fig. 2) .
To evaluate the value of peritoneal washing cytology as an independent prognostic determinant, multivariate analysis was performed with prognostic factors that had been found to be significant by the univariate analyses. The analysis identified lymph node metastasis as the only variable for independently predicting overall survival (P ϭ 0.0004; Table 3 ), whereas CY was found not to be significant.
DISCUSSION
Exfoliation of free malignant cells is a well-described feature of human carcinomas. Malignant transformation of cells alters the expression of surface adhesion molecules and thus facilitates their release into the peritoneal cavity. 12 Microscopic occult peritoneal metastases are thought to precede the emergence of macroscopic peritoneal metastases. 13, 14 In gynecologic malignancies, presence of malignant cells in FIGURE 1. Comparison of survival curves of patients with pancreatic cancer with (CYϩ) and without (CYϪ) tumor cells in peritoneal washings. The overall survival for CYϩ patients was significantly worse than for CYϪ patients (P ϭ 0.047).
FIGURE 2.
Comparison of survival curves of patients with pancreatic cancer who underwent curative resection with (CYϩ) and without (CYϪ) tumor cells in cytologic washings. The median survival time of CYϩ patients was 13.6 months and that of CYϪ patients was 13.5 months (P ϭ 0.269). Comparison of survival curves of patients with pancreatic cancer who did not undergo curative resection with (CYϩ) and without (CYϪ) tumor cells in peritoneal washings. The median survival time of CYϩ patients was 5.9 months and that of CYϪ patients was 6.1 months (P ϭ 0.977). Among pancreatic cancer patients with positive peritoneal cytology, patients with resectable lesions lived longer than patients with nonresectable lesions (P ϭ 0.019). peritoneal washings has been proven to have a strong negative impact on prognosis and therefore has been incorporated into the staging systems of these malignancies. 15 Similarly, peritoneal washing cytology has been used extensively in gastric cancer, 16 -18 and the results are reflected in the Japanese clinical staging scheme. 19 However, the significance and prognostic value of peritoneal washing cytology have yet to be established in other gastrointestinal malignancies, including pancreatic cancer. 20 Several recent studies have reported that patients with pancreatic cancer who are CYϩ are more likely to have advanced stage disease, early metastasis, and a poor prognosis. [2] [3] [4] [5] [6] [7] [8] [9] In some series, overall survival of CYϩ patients was shorter than that of CYϪ patients. 2, 5, 9 CYϩ status has not been reported to be an independent prognostic variable of survival because it seems to be dependent on tumor stage. 5 Some investigators have concluded that tumor cells in the peritoneal washings are precursors of macroscopic dissemination, and have recommended that CYϩ patients not undergo resection even if they would otherwise be surgical candidates. 21 However, we have previously found no correlation between CY status and the incidence of peritoneal carcinomatosis during follow-up and concluded that CYϩ in the absence of gross peritoneal deposits does not represent an absolute contraindication to radical surgery. 7 In addition, Meszoely et al 9 reported that overall survival and disease-free survival are not affected by the presence of tumor cells in peritoneal washings of patients who underwent curative resection. These results suggest that not all cells shed by a pancreatic cancer develop into peritoneal metastases.
While maintaining that surgery cannot in theory be recommended for CYϩ patients, Yachida et al 8 acknowledged that it may be premature to state this categorically given the paucity of outcome data. To the authors' knowledge, the analysis in the current study is based on the largest data set in the literature (Table 4) . Consequently, these results should be weighted more heavily than those from smaller studies.
Although the overall survival for CYϩ patients was worse than for CYϪ patients, CY status did not predict survival within the group of patients who underwent resection or in the group who did not. Resectability was a much stronger determinant of outcome, and long-term survival in CYϩ patients has been documented in this study and others. 5, 7 Thus, it should be considered an independent prognostic factor, and patients whose pancreatic cancer is resectable should not be denied based on CY status alone.
It is unclear why free cancer cells in the abdominal cavity do not have an impact on survival. It may be due in part to differences in the biology of different histologic types. In gastric cancer, patients with undifferentiated adenocarcinoma have a higher rate of CYϩ than those with differentiated adenocarcinoma, 22 whereas most patients with CYϩ in the current study had a moderately differentiated phenotype. However, no correlation existed between CY status and the histopathologic type of pancreatic cancer. Even in gastric cancer, a certain amount of time is needed for isolated tumor cells to develop into peritoneal carcinomatosis. Thus, some CYϩ patients may die due to other patterns of metastatic spread before signs of peritoneal metastasis can develop. This may be the case with at least some CYϩ patients since a high proportion of patients with this cancer die of liver metastasis.
Of the 21 patients with macroscopic peritoneal deposits, only 15 patients (71.4%) were CYϩ, indicating that sensitivity of the examination is a matter of concern. Various techniques such as immunocytochemistry 7, 23 or reverse-transcriptase polymerase chain reaction 24 have been used to improve sensitivity. The authors have previously shown that immunocytochemical staining is more sensitive than conventional staining, 7 and reverse-transcriptase polymerase chain reaction appears to be even more sensitive in gastric cancer. 24 Further study is needed to determine the best method for detecting pancreatic cancer cells in peritoneal washings. However, whether an improvement in sensitivity will increase value of this examination as a prognostic determinant remains unknown. 
